CST3 and atherosclerosis: The current study was designed to investigate whether there is an independent association of cystatin C with the presence and severity of asymptomatic CAD in MetS patients with normal kidney function and to explore the relationship between cystatin C and other biochemical risk factors for atherosclerosis.